Advertisement

News

  • COPD: Could there be a GLP-1 for that?

    COPD: Could there be a GLP-1 for that?

    While real-world data are promising, experts Dinah Foer, MD, and William B. Feldman, MD, say more randomized controlled trials are needed to confirm whether antihyperglycemic medications can improve respiratory outcomes in patients with comorbid type 2 diabetes and COPD.


  • Study highlights importance of lactation among many new mothers in ICU

    Study highlights importance of lactation among many new mothers in ICU

    Researcher, Kayla Kolbe, MD, said even in the face of critical illness, patients feel strongly about lactation.


  • TETON trials could herald multimodal approach to IPF

    TETON trials could herald multimodal approach to IPF

    Steven Nathan, MD, said the addition of inhaled treprostinil would offer a novel approach that would allow clinicians to target the disease on two fronts.


  • Data support early prone positioning for patients with COVID-19 on mechanical ventilation

    Data support early prone positioning for patients with COVID-19 on mechanical ventilation

    Viren Kaul, MD, FCCP, said a recent observational study adds to the body of literature clarifying the optimal timing of prone positioning in this population.


  • Parkinson’s drug shows promise as treatment for nicotine addiction in mouse model

    Parkinson’s drug shows promise as treatment for nicotine addiction in mouse model

    Tobacco cessation expert, Carolyn Dresler, MD, MPA, said new evidence of cross talk between different types of acetylcholinergic receptors could be an important step for future research to determine if, and at what doses, these results could be replicated in humans.


  • Early treatment with CPAP may reduce dementia risk for patients with OSA

    Early treatment with CPAP may reduce dementia risk for patients with OSA

    Sreelatha Naik, MD, FCCP, said the apparent benefit of CPAP therapy is not a surprise; however, more studies are needed to determine if treating sleep apnea can truly mitigate the higher risk of dementia.


  • Corticosteroid benefits unclear for acute ILD exacerbations

    Corticosteroid benefits unclear for acute ILD exacerbations

    Erin Meier, MD, and Rachana Krishna, MBBS, MSCR, discuss the clinical implications of a recent meta-analysis, which suggests steroids may not help all patients with interstitial lung disease (ILD) who experience a flare.


  • Older patients have improved five-year survival for bilateral vs single lung transplant

    Older patients have improved five-year survival for bilateral vs single lung transplant

    Investigator, Haytham Elgharably, MD, discusses the practical implications of his recent research on bilateral lung transplant.


  • GLP-1 receptor agonists for managing OSA: Practical insights from an endocrinologist-sleep specialist

    GLP-1 receptor agonists for managing OSA: Practical insights from an endocrinologist-sleep specialist

    Brian Wojeck, MD, MPH, outlines the clinical considerations sleep medicine specialists will increasingly need to know to treat patients with obesity-related sleep apnea.


  • RSV vaccination boosts antibody titers in individuals with compromised immune systems

    RSV vaccination boosts antibody titers in individuals with compromised immune systems

    Rachana Krishna, MBBS, MSCR, said that while a recent study may not provide the ideal efficacy outcome data, the results are still helpful in counseling this patient population.